⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 11, 2024

[Clinical observation of the subthreshold micropulse laser combined with ranibizumab for treatment of diabetic macular edema].

Xiang Gu Shuang Song Hong Dai Xiaobing Yu

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate the efficacy and safety of the subthreshold micropulse laser (SMPL) combined with ranibizumab in treating diabetic macular edema (DME).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gu et al. (2024) studied this question.

synapsesocial.com/papers/68e609ceb6db64358759d953 https://doi.org/10.3760/cma.j.cn112142-20231227-00314

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Short Pulse Grid and Subthreshold Micropulse Laser (the Sandwich Grid) Plus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema2024
2Effect of ranibizumab combined with laser photocoagulation in the treatment of diabetic macular edema2024
3Subthreshold Micropulse Laser and Conventional Subthreshold Laser in Diabetic Macular EdemaRandomized Controlled Trial · 2026
4Six-month results of 577 nm subthreshold micropulse laser therapy in non-center involving diabetic macular edema2024 · 2 citations
5Conbercept combined with 577 nm subthreshold micropulse laser for diabetic macular edema2025